Quarterly report [Sections 13 or 15(d)]

Stock-based Compensation

v3.25.3
Stock-based Compensation
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation

Note 10 – Stock-based Compensation

 

2013 Plan

 

The Company’s Amended and Restated 2013 Equity Compensation Plan (the “2013 Plan”), which expired on May 7, 2024, provided for the granting of incentive stock options, nonqualified stock options, restricted stock units, performance units, and stock purchase rights. The term of the 2013 Plan was for 10 years.

 

As of September 30, 2025, there were 434,334 awards, including both restricted stock grants and option grants, issued and exercised under the 2013 Plan and no remaining shares available for grant under the 2013 Plan.

 

2025 Plan

 

On April 30, 2025, the Company’s board of directors (the “Board”), subject to the approval of its stockholders which was received on June 23, 2025, adopted a new 2025 Equity Incentive Plan (the “2025 Plan”) to succeed the 2013 Plan.

 

As of September 30, 2025, there were 116,500 option grant awards issued and outstanding under the 2025 Plan and 646,548 awards available for grant under the 2025 Plan.

 

The Company recognized stock-based compensation expense (options and restricted share grants) in its condensed consolidated statements of operations as follows:

 

    2025     2024     2025     2024  
   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
    2025     2024     2025     2024  
Research and Development   $     $ 387     $ 85     $ 1,212  
General and Administrative     253       578       721       1,739  
Total   $ 253     $ 965     $ 806     $ 2,951  

 

As of September 30, 2025, total compensation costs related to unvested awards not yet recognized was $990 and the weighted-average periods over which the awards are expected to be recognized was 1.7 years.

 

Stock Options

 

The following table summarizes the activity for Company’ stock options for the nine months ended September 30, 2025:

 

    Stock Options  
Outstanding at December 31, 2024     687,356  
Granted     116,500  
Exercised      
Forfeited     (3,101 )
Expired     (343,536 )
Outstanding at September 30, 2025     457,219